NILHANZA
Live / Applied — Fourth extension granted (statement of use) (as of 25 Feb 2026)
What this means for you
Not registered yet, but its 27 Jan 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97771180
- Mark type
- Stylized text
- Filed
- 27 Jan 2023
- Published for opposition
- 09 Jan 2024
- Attorney of record
- James A. Wahl
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, those for use in human oncology; Tyrosine kinase inhibitors for use in the treatment of cancer; Drugs in the nature of pharmaceutical preparations for use in treating chronic myelogenous leukemia
Owner
- FLEX PHARMA, LLC, MINNEAPOLIS, MN, US
- Nanocopoeia, LLC, Minneapolis, MN, US
- Nanocopoeia, LLC, New Brighton, MN, US
Prosecution history
- 25 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Feb 2026 — SOU EXTENSION 4 GRANTED
- 23 Feb 2026 — SOU EXTENSION 4 FILED
- 24 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Sept 2025 — SOU EXTENSION 3 GRANTED
- 03 Sept 2025 — SOU EXTENSION 3 FILED
- 03 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 29 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jun 2025 — SOU EXTENSION 2 GRANTED
- 03 Mar 2025 — SOU EXTENSION 2 FILED
- 27 Jun 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 Jun 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 04 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED